Loading...
•
Dec 31, 2022
UFP Technologies Q4 2022 Earnings Report
Reported record results driven by acquisitions and organic growth.
Key Takeaways
UFP Technologies reported strong Q4 2022 results with a significant increase in sales and earnings per share compared to the same period in 2021. The company's performance was boosted by recent acquisitions and organic growth, with a positive outlook for the future.
Net sales for the fourth quarter of 2022 were $91.2 million, compared to $56.3 million in the fourth quarter of 2021.
Net income for the fourth quarter of 2022 was $8.5 million, or $1.10 per diluted share, compared to $3.2 million, or $0.42 per diluted share, for the fourth quarter of 2021.
The company integrated key acquisitions, including DAS Medical, Contech Medical, and Advant Medical, which contributed to the overall growth.
Base business grew organically at an impressive 18.6% in 2022
Forward Guidance
The company anticipates continued growth and benefits from acquisition synergies and investments in facilities and talent. They expect to maintain a strong balance sheet, enabling further growth initiatives.
Positive Outlook
- Realizing acquisition synergies.
- Gaining benefits of recent investments in new clean rooms.
- Gaining benefits of recent investments in production capacity.
- Gaining benefits of recent investments in talent.
- Strong balance sheet allowing execution of additional internal and external growth initiatives.
Challenges Ahead
- Challenging supply chain issues.
- Difficult labor market.
- Fluctuations in supply, demand and prices for the Company's products and services.
- Ability to achieve anticipated benefits of recent acquisitions
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...